UPDATE: Goldman Sachs Downgrades Singular Genomics (OMIC) to Neutral
Tweet Send to a Friend
(Updated - August 10, 2022 5:21 AM EDT)
Goldman Sachs analyst Matthew Sykes downgraded Singular Genomics (NASDAQ: OMIC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes downgraded Singular Genomics (NASDAQ: OMIC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
